Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

Tom de Leeuw; L Mangiarini; R Lundin; F Kaguelidou; Tjitske Zanden; O Della Pasqua; Dick Tibboel; A Ceci; Saskia de Wildt

doi:10.1186/s13063-018-3169-3

Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

Tom de Leeuw, L Mangiarini, R Lundin, F Kaguelidou, Tjitske Zanden, O Della Pasqua, Dick Tibboel, A Ceci, Saskia de Wildt

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	49
Journal	Trials
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s13063-018-3169-3
Publication status	Published - 2019

Access to Document

10.1186/s13063-018-3169-3

Cite this

de Leeuw, T., Mangiarini, L., Lundin, R., Kaguelidou, F., Zanden, T., Della Pasqua, O., Tibboel, D., Ceci, A., & de Wildt, S. (2019). Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials, 20(1), 49. https://doi.org/10.1186/s13063-018-3169-3

@article{e95b67676a2e499b9d2278f7b9607222,

title = "Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial",

author = "{de Leeuw}, Tom and L Mangiarini and R Lundin and F Kaguelidou and Tjitske Zanden and {Della Pasqua}, O and Dick Tibboel and A Ceci and {de Wildt}, Saskia",

year = "2019",

doi = "10.1186/s13063-018-3169-3",

language = "Undefined/Unknown",

volume = "20",

pages = "49",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

number = "1",

}

de Leeuw, T, Mangiarini, L, Lundin, R, Kaguelidou, F, Zanden, T, Della Pasqua, O, Tibboel, D, Ceci, A & de Wildt, S 2019, 'Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial', Trials, vol. 20, no. 1, pp. 49. https://doi.org/10.1186/s13063-018-3169-3

Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. / de Leeuw, Tom; Mangiarini, L; Lundin, R et al.

In: Trials, Vol. 20, No. 1, 2019, p. 49.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

AU - de Leeuw, Tom

AU - Mangiarini, L

AU - Lundin, R

AU - Kaguelidou, F

AU - Zanden, Tjitske

AU - Della Pasqua, O

AU - Tibboel, Dick

AU - Ceci, A

AU - de Wildt, Saskia

PY - 2019

Y1 - 2019

U2 - 10.1186/s13063-018-3169-3

DO - 10.1186/s13063-018-3169-3

M3 - Article

VL - 20

SP - 49

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

ER -

de Leeuw T, Mangiarini L, Lundin R, Kaguelidou F, Zanden T, Della Pasqua O et al. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3?months to 18?years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials. 2019;20(1):49. doi: 10.1186/s13063-018-3169-3